Dosidal · Switzerland
Pamorelin LA 3.75 mg, poudre et solvant pour suspension injectable à libération prolongée
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Switzerland |
|---|---|
| Record | ch:authorisation:52815 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | swissmedic-authorisation: 52815 atc: L02AE04 |
| Source authority | Swissmedic |
| Read date | |
| authorisation status | first_authorisation: 1998-01-14 term: zugelassen valid_until: 9999-12-31 state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| identity | atc: L02AE04 authorisation_number: 52815 form: PULMS holder: Debiopharm Research & Manufacturing SA holder_partner_nr: 1006677 it_number: 07.16.2. name: Pamorelin LA 3.75 mg, poudre et solvant pour suspension injectable à libération prolongée state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53TAs3Dc_GQ--_9A_1U_pGoVUf0GXBgjppCsaw1oP5rKy0inXbaj1M-nw61XPhUcoA6n3CFbzuYx6UJYhjzy1yzwVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |